Mr Richard Kerr qualified from The London Hospital, and trained in surgery and neurosurgery in London, Oxford and Melbourne. Based at the John Radcliffe Hospital in Oxford, he has been consultant for 30years. With a wide cranial and spinal practice, he has subspecialty interests in skull base tumours, oncology and vascular disease. He devised and runs the Oxford Skull Base Practice and is a member of the NFII clinic, a nationally co-ordinated regional service. Research has led to publication of over 40 peer reviewed articles and 15 book chapters. He was Co-Principal Investigator in the MRC funded International Subarachnoid Aneurysm Trial (ISAT). The publication of this trial has led to a global change in the management of aneurysmal subarachnoid haemorrhage, with invitations to speak to learned societies from all over the world. Active in management, and trained as a civil and commercial mediator, he has been Lead Clinician of the Neurosurgical Department, Clinical Centre Chairman of the Radcliffe Infirmary and Chairman of the Relocation Steering Committee of Services to the John Radcliffe Hospital. Elected to the Council of the Society of British Neurological Surgeons (SBNS) in 2003, he was appointed Treasurer of the SBNS in 2010 and Member of the Neurosurgical SAC in 2011. He is President-Elect of the SBNS, taking up office of President of the SBNS from September 2014-2016. With interests in co-operation between the specialist surgical associations, audit and surgical outcome data, he was elected to council of The Royal College of Surgeons of England in 2013, and was re-elected in 2019 having served as Trustee from 2015-2017. He chaired the independent commission on the Future of Surgery, published in December 2019.